Infectious Diseases Market Research Reports & Industry Analysis
Infectious Diseases Industry Research & Market Reports
-
The 2025-2030 World Outlook for Infectious Disease Treatments
... potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to quickly ... Read More
-
The 2025-2030 World Outlook for Infectious Disease Testing Products
... demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader ... Read More
-
The 2025-2030 World Outlook for Communicable Diseases
... earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to quickly gauge a ... Read More
-
The 2025-2030 World Outlook for Healthcare Acquired Infections
... potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to quickly ... Read More
-
The World Market for Vaccines, 2024
... adoption of effective vaccines has led to the near-elimination of many deadly diseases, making vaccination one of the greatest public health achievements of the 20th century. Thanks to public vaccination programs, vaccine-preventable diseases and related ... Read More
-
Global Vaccine Adjuvants Market Size study&Forecast, byType (Pathogen, Adjuvant emulsion, Particulate, Combination, Others), by Application (Infectious diseases, Cancer, Others), by Administration (Oral, Intradermal, Intranasal, Intramuscular, Others) and Regional Analysis, 2023-2030
... valued at approximately USD1.62 billion in 2022 andis anticipated to grow with a healthy growth rate of more than 2.3%duringthe forecast period 2023-2030.Adjuvants are the ingredients that are added to the vaccinations to increase effectiveness ... Read More
-
Global Antisense and RNAi therapeutics Market Size study & Forecast, by Technology (RNA Interference, Antisense RNA) by Application (Genetic Disease, Cancer, Infectious Disease, Neurodegenerative Disorders, Cardiometabolic & Renal Disorders, Ocular Disorders, Respiratory Disorders, Skin Disorders), by Route of Administration (Intravenous Injections, Intrathecal Injections, Subcutaneous Injections, Other Delivery Methods), and Regional Analysis, 2023-2030
... by Route of Administration (Intravenous Injections, Intrathecal Injections, Subcutaneous Injections, Other Delivery Methods), and Regional Analysis, 2023-2030 Global Antisense and RNAi therapeutics Market is valued approximately at USD 3.69 billion in 2022 and is anticipated ... Read More
-
Gene Therapy Market Assessment, By Type [Gene Silencing, Cell Replacement, Gene Augmentation, Others], By Vector [Non-Viral Vectors, Viral Vectors], By Gene Delivery Method [Ex vivo and In vivo], By Application [Oncological Diseases, Neuromuscular Diseases, Cardiovascular Diseases, Infectious Diseases, Genetic Diseases, Haematological Diseases, Others], By Route of Administration [Intravenous, Oral, Intramuscular, Others], By End-users [Hospitals, Cancer and Research Institutes, Clinics, Others], By Region, Opportunities and Forecast, 2017-2031F
... Diseases, Infectious Diseases, Genetic Diseases, Haematological Diseases, Others], By Route of Administration [Intravenous, Oral, Intramuscular, Others], By End-users [Hospitals, Cancer and Research Institutes, Clinics, Others], By Region, Opportunities and Forecast, 2017-2031F Global gene therapy market ... Read More
-
Highly Potent API Market - A Global and Regional Analysis: Focus on Type, Type of Synthesis, Therapeutic Area, Type of Manufacturing, End User, and Country - Analysis and Forecast, 2023-2033
... Market The global highly potent API market is projected to reach $84.20 billion by 2033 from $27.44 billion in 2023, growing at a CAGR of 11.86% during the forecast period 2023-2033. The key factors driving ... Read More
-
H3N2 infection - Pipeline Insight, 2024
... clinical and nonclinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space. Geography Covered Global coverage ... Read More
-
2024 Global Forecast for Hospital Acquired Infection Control Market (2025-2030 Outlook)-High Tech & Emerging Markets Report
... product or service category is within the NAICS Chemical Manufacturing industry. The product or service category is within the NAICS Chemical Manufacturing industry. The global market is expected to increase from USD xx billion in ... Read More
-
APAC PCR-based Infectious Diseases Market - Industry Trends and Forecast to 2032
... a CAGR of 7.4% in the forecast period of 2024 to 2031. Market Segmentation Asia-Pacific PCR-based Infectious Diseases Market, By Test Type (Tuberculosis PCR Test, Hepatitis PCR Test, Human Immunodeficiency Virus (HIV) PCR Test, Influenza ... Read More
-
Chagas Disease: American trypanosomiasis Market
... a detailed competitive environment analysis. The scope of this report covers treatment throughout Latin America. Report Includes: An overview of the global chagas disease (T. cruzi infection) market Analyses of the global market trends, with ... Read More
-
Immunotherapy Drugs Market (Drug Type: Monoclonal Antibodies, Immunomodulators, Cell Therapy and Others; and Therapy Area: Cancer, Autoimmune Diseases, Infectious Diseases, and Others) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2023-2031
... Market – Scope of Report TMR’s report on the global immunotherapy drugs market studies the past as well as the current growth trends and opportunities to gain valuable insights of the indicators of the market ... Read More
-
Central Nervous System Therapeutics Market by Diseases (Cancer, Degenerative Diseases, Infectious Diseases), Drug Class (Analgesics, Anesthetics, Anti-Epileptics), End-Users - Global Forecast 2024-2030
... in 2023 and expected to reach USD 76.41 billion in 2024, at a CAGR 9.37% to reach USD 131.39 billion by 2030. FPNV Positioning Matrix The FPNV Positioning Matrix is pivotal in evaluating the Central ... Read More
-
Bovine Respiratory Disease Treatment Market by Disease Type (Diphtheria, Pneumonia, Upper Respiratory Tract Infections), Treatment Type (Antibiotics, Immunomodulators, Vaccines), Distribution Channel - Global Forecast 2024-2030
... USD 1.96 billion in 2023 and expected to reach USD 2.10 billion in 2024, at a CAGR 7.58% to reach USD 3.27 billion by 2030. Global Bovine Respiratory Disease Treatment Market FPNV Positioning Matrix The ... Read More
-
Antisense & RNAi Therapeutics Market by Technology (Antisense RNA, RNA Interference), Application (Cardiovascular Diseases (CVDs), Genetic Disorders, Infectious Diseases), Route of Administration - Global Forecast 2024-2030
... at USD 4.51 billion in 2023 and expected to reach USD 4.93 billion in 2024, at a CAGR 9.34% to reach USD 8.43 billion by 2030. FPNV Positioning Matrix The FPNV Positioning Matrix is pivotal ... Read More
-
Digital Respiratory Devices Market by Product (Sensors & Apps, Smart Inhalers & Nebulizers), Disease Indications (Asthma, COPD, Infectious Diseases), Distribution Channel, End-Use - Global Forecast 2024-2030
... USD 23.45 billion in 2023 and expected to reach USD 30.61 billion in 2024, at a CAGR 30.95% to reach USD 154.87 billion by 2030. FPNV Positioning Matrix The FPNV Positioning Matrix is pivotal in ... Read More
-
In Silico Clinical Trials Market by Therapeutic Area (Infectious Diseases, Oncology), Phase (Phase I, Phase II, Phase III), Industry - Global Forecast 2024-2030
... billion in 2023 and expected to reach USD 3.19 billion in 2024, at a CAGR 7.01% to reach USD 4.85 billion by 2030. Global In Silico Clinical Trials Market FPNV Positioning Matrix The FPNV Positioning ... Read More
-
Biologics Market by Product (Cellular Based Biologics, Gene Based Biologics, Monoclonal Antibodies), Indication (Autoimmune Diseases, Cancer, Infectious Diseases), End-user - Global Forecast 2024-2030
... and expected to reach USD 302.68 billion in 2024, at a CAGR 5.39% to reach USD 415.18 billion by 2030. Global Biologics Market FPNV Positioning Matrix The FPNV Positioning Matrix is pivotal in evaluating the ... Read More
-
Infectious Disease Therapeutics Market by Drug (Antibiotics, Antifungal Drugs, Antiparasitic Drugs), Route of Administration (Intravenous, Oral, Topical), Disease, Distribution Channel, End-User - Global Forecast 2024-2030
... 116.21 billion in 2023 and expected to reach USD 121.27 billion in 2024, at a CAGR 4.41% to reach USD 157.28 billion by 2030. Global Infectious Disease Therapeutics Market FPNV Positioning Matrix The FPNV Positioning ... Read More
-
Pneumonia Testing Market by Type (Instruments, Reagents & Consumables), Method (Immunodiagnostics, Molecular Diagnostics, Point of Care Testing), Technology, End-user - Global Forecast 2024-2030
... 2023 and expected to reach USD 1.58 billion in 2024, at a CAGR 6.23% to reach USD 2.28 billion by 2030. Global Pneumonia Testing Market FPNV Positioning Matrix The FPNV Positioning Matrix is pivotal in ... Read More
-
Auto-disable Syringes Market by Indication (Infectious Diseases, Inflammatory/Auto-Immune Diseases), Application (Blood Collection, Drug Delivery, Vaccination), End-User - Global Forecast 2024-2030
... to reach USD 25.94 billion in 2024, at a CAGR 11.54% to reach USD 50.01 billion by 2030. FPNV Positioning Matrix The FPNV Positioning Matrix is pivotal in evaluating the Auto-disable Syringes Market. It offers ... Read More
-
Therapeutic Vaccines Market by Vaccines Type (Auto-Immune Diseases Vaccines, Chronic Disease Vaccines, Infectious Diseases Vaccines), Disease Indication (Dengue, DTP, Hepatitis), Administration, End-User - Global Forecast 2024-2030
... 30.08 billion in 2023 and expected to reach USD 33.05 billion in 2024, at a CAGR 10.35% to reach USD 59.95 billion by 2030. Global Therapeutic Vaccines Market FPNV Positioning Matrix The FPNV Positioning Matrix ... Read More
-
mRNA Vaccines in Infectious Diseases Market Overview
... Current Companies and Brief Market Outlook Messenger RNA (mRNA) is a single-stranded ribonucleic acid that is transcribed from a strand of DNA. mRNA carries the coding information for protein synthesis. mRNA vaccines use mRNA that ... Read More
Research Assistance
